Iron Direct Primary Care

04/07/2026

Reflecting on my lipid denialism past now with new informationHuman optimization isn't living with an LDL of 190. We don't do that for anything else in functional medicine why do we say it's ok to live with high LDL if it's in the lab normal reference range. New data from the 2026 ACC guideline say optimize LDL way below 100 especially if risk factors present.

04/07/2026

Galectin-3: A Molecular Link to Fibrosis, Heart Failure, cancer

Galectin-3 (Gal-3) is a β-galactoside-binding lectin released by inflammatory cells, particularly macrophages, in response to myocardial stress or injury. It acts as a pivotal mediator in the transition from inflammation to fibrosis. Gal-3 binds to receptors on cardiac fibroblasts, stimulating their activation, proliferation, and differentiation into myofibroblasts. This leads to increased collagen synthesis and deposition in the extracellular matrix, resulting in myocardial stiffness, adverse ventricular remodeling, and eventual heart failure (HF).

Clinically, Gal-3 has emerged as a valuable biomarker for laboratory monitoring in cardiovascular disease management. FDA-cleared assays provide quantitative measurement in serum or plasma. Key reference ranges for risk stratification include:

The 17.8 ng/mL threshold is FDA-cleared for identifying patients at higher risk of adverse outcomes. Studies demonstrate that elevated Gal-3 levels strongly predict HF hospitalization, mortality, and disease progression, offering complementary prognostic information alongside natriuretic peptides (e.g., NT-proBNP).

In direct primary care settings, Gal-3 testing is particularly useful for:
1. Risk stratification in patients with hypertension, diabetes, or early cardiac remodeling.
2. Prognostication in diagnosed chronic HF (HFrEF or HFpEF).
3. Guiding therapeutic decisions – elevated levels (≥17.8 ng/mL) may prompt optimization of guideline-directed medical therapy (ACEi/ARBs, mineralocorticoid antagonists, SGLT2i) to target fibrosis.
4. Potential serial monitoring (e.g., semi-annually in at-risk patients) to assess response to interventions aimed at preventing or slowing fibrotic progression.

Cost: $68 with Iron DPC’s lab rates

04/07/2026

Understanding the link between saturated fats and LDL-C is key. My approach? Enjoy the foods I love, supported by medication to keep my lipid levels in check. It's about balance and informed choices.

04/06/2026

Repurposing Rosuvastatin for Functional Medicine!

Statins like Rosuvastatin are primary tools for reducing high cholesterol. Emerging evidence shows it possesses beneficial effects far beyond its intended purpose. In a functional medicine context, we are shifting from a single-focus approach to one that utilizes this medication as a potent modulator of systemic inflammation, oxidative stress, and immune dysregulation — known root causes of chronic illness.
Beyond the Lipid Panel
The traditional approach to healthcare often zeroes in on a single marker, like LDL "bad" cholesterol. While this is a useful metric, it’s not the complete picture of wellness. Chronic inflammation and oxidative stress are often the true drivers of disease, yet they can be missed by standard protocols. A functional medicine framework looks at the big picture and seeks to intervene at these systemic levels.
A Tool for Systemic Health
Rosuvastatin’s primary action is well-known: it stops cholesterol synthesis. However, it’s also an powerful anti-inflammatory and an antioxidant. This multi-target effect makes it uniquely suitable for a functional medicine approach.
Key non-lipid actions include:
* Modulating systemic inflammation (lowering markers like hs-CRP).
* Reducing oxidative stress.
* Optimizing endothelial function (the lining of blood vessels).
* Balancing immune responses.
Functional medicine uses this drug not as a simple solution for a symptom, but as a strategic tool to update and improve the function of vital physiological systems.
Optimizing Outcomes
This systems-based approach targets a more comprehensive form of health. While it may also be used in more complex conditions like Lyme disease or Long COVID due to its inflammation-reducing properties, its broader application is for anyone seeking optimized health and resilience. The result is a more personalized plan that supports overall health span and systemic wellness. It represents an exciting fusion of pharmacology and holistic medicine, providing a better, more integrative path to a healthier life.

04/06/2026

We have quite a hot topic to discuss this week on the Iron Direct Primary Care podcast


We didn't change our minds because it was popular—we changed them because the data gave us no choice.Most people treat their diet like a religion, but in fun...

04/06/2026

A shift in practice acknowledges that diet and exercise aren't always enough. For true longevity, pharmacology plays a critical role, a lesson learned from patients with persistent poor lab results.

04/06/2026

Discover how a vegetarian diet, rich in soy protein and fiber, can significantly lower LDL-C. Learn why saturated fats from red meat and butter raise cholesterol and how plant-based foods offer a healthier alternative.

04/05/2026

One woman's months-long struggle for answers about severe menopause symptoms like weight gain, fatigue, and anxiety. After being bounced between doctors, she finally found help where her condition is routinely treated.

04/05/2026

The Biphasic Conundrum of Extreme Diets

Keto/Carnivore vs. Vegan/Vegetarian
both ends of the spectrum promise quick wins… but what happens long-term?

Left Side: Keto/Carnivore
✅ Short-term: Ketosis, rapid weight loss, reduced inflammation
❌ Long-term risks:
- Elevated LDL cholesterol
- Higher triglycerides
- Kidney stones
- Gout

Right Side: Vegan/Vegetarian
✅ Short-term: Antioxidants, fiber for gut health, weight control
❌ Long-term risks:
- Declining bone mineral density
- B12 & ferritin deficiency
- Omega-3 deficiency
- Protein, iron, and zinc shortfalls
- Low vitality & nutrient deficiency risks

In the middle? A balanced, whole-foods approach focused on:
- Muscle mass & bone density
- Energy & vitality
- Insulin sensitivity
- Stabilized hormones & lipids
- Gut health & immunity
- True sustainability

Initial benefits often give way to long-term disease risk at both extremes.

Extreme versions of any diet can create imbalances. Real, lasting health lives in the sustainable middle ground — nutrient-dense, whole foods that support your body without forcing it into one rigid corner.

What’s your experience with extreme diets? Have you seen the honeymoon phase fade? Drop your thoughts below 👇

Sustainable health > temporary results.

04/05/2026

Discover how simple dietary shifts, like cutting back on red meat and boosting your intake of fiber-rich foods, can make a noticeable difference in your LDL cholesterol levels.

04/04/2026

We are here to dispel a persistent health myth: that cardio-vascular disease (CVD) only happens when you are both insulin resistant AND have high lipids.

That was once under the illusion that if you’re athletic and lean with great influence sensitivity like I am that lipids don’t matter so much. But I don’t believe that anymore.

Why You Can't Ignore Either Axis: The Citations

The conceptual framework of this graphic is built upon decades of epidemiological and mechanistic studies.

1. The Power of Accumulated LDL Exposure

The central argument—that high lipids (dyslipidemia), especially LDL cholesterol, independently drive risk over decades—is validated by one of the most comprehensive consensus statements available.

Study: "Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel."

Publication: European Heart Journal, 2020.

Key Finding: This extensive meta-analysis confirms a causal relationship between cumulative exposure to LDL cholesterol and the risk of ASCVD (Atherosclerotic Cardio-Vascular Disease). This directly validates the "Case 2" curve (Dyslipidemia Only) and the overall conceptual model: the more decades you are exposed to high lipids, the higher your plaque buildup, regardless of other factors. It’s about chronic, cumulative damage, which is why risk accrues over 60 years in our timeline.

2. The Power of Independent Insulin Resistance

On the other axis, we established that insulin resistance is not just a precursor to diabetes, but a direct vascular toxin.

Study: "Insulin Resistance: A Causal Factor in ASCVD."

Publication: The Journal of Clinical Investigation, 2012.

Key Finding: This review details how insulin resistance, even before it manifests as high blood sugar, creates endothelial dysfunction (damaging the blood vessel lining) and promotes plaque formation. This citation directly validates the "Case 1" curve (Insulin Resistance Only). Being fit and insulin sensitive doesn't 'protect' your arteries from the cumulative damage of insulin itself.

3. The Exponential 'Multiplier Effect'

Finally, we highlighted the critical finding: that having both conditions creates a synergy of risk that doesn't just add up, it multiplies.

Study: "Synergy of Risk Factors for Cardiovascular Disease in the Community."

Publication: Circulation, 2005 (Framingham Heart Study).

Key Finding: Analyzing decades of data from the landmark Framingham study, researchers demonstrated that risk factors do not just sum, they multiply your risk of major coronary events. This data is the foundation of the towering red summit (Maximum Risk) in our graphic.

The Clear Message to You

This infographic serves as a unified conceptual model, built on these foundational pillars of science. The message is clear:

Stop Managing for 'Good Enough': You cannot afford to prioritize one metric (like insulin sensitivity) while ignoring another (like lipids).

Long-Term Exposure Matters: The 'Case 1' and 'Case 2' curves show that risk accumulates chronically. What feels manageable today is compounding damage for decades down the line.

Maximum Optimized is the Goal: There is only one true 'safe zone' in the green valley, and it requires both metabolic health AND lipid optimization.

Let's use this science-validated tool to shift the conversation from a singular focus to comprehensive cardiovascular optimization.

04/04/2026

Beyond menopause relief, hormone replacement therapy plays a crucial role in protecting against heart disease, bone loss, and cognitive decline. Hormone deficiency significantly impacts women's well-being, especially in their early 60s.